Carbidopa and levodopa and Hallucination, visual - a phase IV clinical study of FDA data
Hallucination, visual is found among people who take Carbidopa and levodopa, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Carbidopa and levodopa and have Hallucination, visual. It is created by eHealthMe based on reports of 4,745 people who have side effects when taking Carbidopa and levodopa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
4,745 people reported to have side effects when taking Carbidopa and levodopa.
Among them, 106 people (2.23%) have Hallucination, visual.
What is Carbidopa and levodopa?
Carbidopa and levodopa has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 5,212 Carbidopa and levodopa users for its effectiveness, alternative drugs and more.
What is Hallucination, visual?
Hallucination, visual (seeing things that aren't there) is found to be associated with 1,689 drugs and 1,242 conditions by eHealthMe.
Number of Carbidopa and levodopa and Hallucination, visual reports submitted per year:
Time on Carbidopa and levodopa when people have Hallucination, visual *:
Gender of people who have Hallucination, visual when taking Carbidopa and levodopa*:
Age of people who have Hallucination, visual when taking Carbidopa and levodopa *:
Common drugs people take besides Carbidopa and levodopa *:
Common side effects people have besides Hallucination, visual *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Carbidopa and levodopa and have Hallucination, visual?Check whether Hallucination, visual is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Carbidopa and levodopa:
- Carbidopa and levodopa (5,212 reports)
Hallucination, visual treatments and more:
- Hallucination, visual (18,483 reports)
COVID vaccines that are related to Hallucination, visual:
- Hallucination, visual in Moderna COVID Vaccine
- Hallucination, visual in Pfizer BioNTech Covid Vaccine
- Hallucination, visual in Johnson and Johnson Covid Vaccine
How severe was Hallucination, visual and when was it recovered:
Expand to all the drugs that have ingredients of carbidopa; levodopa:
Common drugs associated with Hallucination, visual:
All the drugs that are associated with Hallucination, visual:
- Hallucination, visual (1,689 drugs)
Common conditions associated with Hallucination, visual:
All the conditions that are associated with Hallucination, visual:
- Hallucination, visual (1,242 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carbidopa; levodopa (the active ingredients of Carbidopa and levodopa) and Carbidopa and levodopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.